Topic: refractory focal epilepsy

Globally, epilepsy afflicts more than 50 million people, and one-third of these individuals remain unresponsive to conventional drugs. In response to this challenge, Transcranial Static Magnetic Stimulation (tSMS) has emerged as a noninvasive neuromodulatory approach capable of reducing heightened cortical excitability, a characteristic feature in various forms of epilepsy. This project aimed to evaluate the effectiveness of a pilot clinical program implementing tSMS for refractory focal epilepsy.Thus far, four patients with refractory focal epilepsy, drawn from the University Hospitals of Cor